Serial cardiac MRI for assessment of cardiac morphology and function in CTEPH patients after PEA or vasodilator therapy
D. Alkhanfar (Sheffield, United Kingdom), Y. Shahin (Sheffield, United Kingdom), F. Alandejani (Sheffield, United Kingdom), S. Alabed (Sheffield, United Kingdom), C. Johns (Sheffield, United Kingdom), A. Mk Rothman (Sheffield, United Kingdom), P. Garg (Sheffield, United Kingdom), R. Condliffe (Sheffield, United Kingdom), R. Quadery (Sheffield, United Kingdom), D. G Kiely (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), A. J Swift (Sheffield, United Kingdom)
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Session: Chronic thromboembolic pulmonary hypertension
Session type: E-poster session
Number: 1540
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Alkhanfar (Sheffield, United Kingdom), Y. Shahin (Sheffield, United Kingdom), F. Alandejani (Sheffield, United Kingdom), S. Alabed (Sheffield, United Kingdom), C. Johns (Sheffield, United Kingdom), A. Mk Rothman (Sheffield, United Kingdom), P. Garg (Sheffield, United Kingdom), R. Condliffe (Sheffield, United Kingdom), R. Quadery (Sheffield, United Kingdom), D. G Kiely (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), A. J Swift (Sheffield, United Kingdom). Serial cardiac MRI for assessment of cardiac morphology and function in CTEPH patients after PEA or vasodilator therapy. 1540
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: